Concepedia

Author

D. Cambridge

Wellcome Trust

Also Known As

Cambridge, David, D Cambridge, D. CAMBRIDGE, D. Cambridge, David Cambridge, David Kimble Cambridge

43

Publications

1.1K

Citations

14

H-Index

33

Concepts

All Affiliations

Wellcome TrustUniversity College LondonPfizer (United Kingdom)
DC

About

D. Cambridge is an author at Wellcome Trust specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

718

2

Anesthesia

2

2

53

3

Natural Sciences

1

1

41

4

Biochemistry

1

1

41

5

Chemistry

1

1

23

D. Cambridge

×

15

Publications

971

Citations

13

H-Index

YearCitations

UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypes

D. Cambridge

European Journal of Pharmacology

1981

289

Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

D. Cambridge, Davey Mj, R. Massingham

Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)

1977

127

THE PHARMACOLOGY OF ANTIHYPERTENSIVE DRUGS WITH SPECIAL REFERENCE TO VASODILATORS, α‐ADRENERGIC BLOCKING AGENTS AND PRAZOSIN

D. Cambridge, Michael Davey, R. Massingham

The Medical Journal of Australia

1977

119

Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse

Daryl D. Rees, Jayne Monkhouse, D. Cambridge,

British Journal of Pharmacology

1998

86

Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines

Graeme R. Martin, P. Leff, D. Cambridge,

Naunyn-Schmiedeberg s Archives of Pharmacology

1987

77

Evaluation of the QA interval as an index of cardiac contractility in anaesthetised dogs: responses to changes in cardiac loading and heart rate

D. Cambridge, M.V. Whiting

Cardiovascular Research

1986

42

Inotropic 'A' ring substituted sulmazole and isomazole analogs

Paul Barraclough, J.W. Black, D. Cambridge,

Journal of Medicinal Chemistry

1990

42

Discovery of 4-[3-(<i>trans</i>-3-Dimethylaminocyclobutyl)-1<i>H</i>-indol-5-ylmethyl]- (4<i>S</i>)-oxazolidin-2-one (4991W93), a 5HT<sub>1B/1D</sub>Receptor Partial Agonist and a Potent Inhibitor of Electrically Induced Plasma Extravasation

Karamjit S. Jandu, Vikki Barrett, Michael Brockwell,

Journal of Medicinal Chemistry

2001

41

The protective action of allopurinol in an experimental model of haemorrhagic shock and reperfusion

G. Allan, D. Cambridge, L. Lee‐Tsang‐Tan,

British Journal of Pharmacology

1986

33

Canine renovascular responses to sumatriptan and 5‐carboxamidotryptamine: modulation through endothelial 5‐HT<sub>1</sub>‐like receptors by endogenous nitric oxide

M.V. Whiting, D. Cambridge

British Journal of Pharmacology

1995

33

Page 1